AI-powered discovery of a novel p53-Y220C reactivator
Open Access
- 1 August 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1229696
Abstract
Introduction: The p53-Y220C mutation is one of the most common mutations that play a major role in cancer progression.Methods: In this study, we applied artificial intelligence (AI)-powered virtual screening to identify small-molecule compounds that specifically restore the wild-type p53 conformation from p53-Y220C. From 10 million compounds, the AI algorithm selected a chemically diverse set of 83 high-scoring hits, which were subjected to several experimental assays using cell lines with different p53 mutations.Results: We identified one compound, H3, that preferentially killed cells with the p53-Y220C mutation compared to cells with other p53 mutations. H3 increased the amount of folded mutant protein with wild-type p53 conformation, restored its transcriptional functions, and caused cell cycle arrest and apoptosis. Furthermore, H3 reduced tumorigenesis in a mouse xenograft model with p53-Y220C-positive cells.Conclusion: AI enabled the discovery of the H3 compound that selectively reactivates the p53-Y220C mutant and inhibits tumor development in mice.Keywords
This publication has 37 references indexed in Scilit:
- The Roles of MDM2 and MDMX in CancerAnnual Review of Pathology: Mechanisms of Disease, 2016
- The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and ProgressionCold Spring Harbor Perspectives in Medicine, 2016
- Small molecule induced reactivation of mutant p53 in cancer cellsNucleic Acids Research, 2013
- Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53Journal of the American Chemical Society, 2012
- Targeted rescue of a destabilized mutant of p53 by an in silico screened drugProceedings of the National Academy of Sciences, 2008
- Structure–function–rescue: the diverse nature of common p53 cancer mutantsOncogene, 2007
- Stabilization of p53 by CP-31398 Inhibits Ubiquitination without Altering Phosphorylation at Serine 15 or 20 or MDM2 BindingMolecular and Cellular Biology, 2003
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Characterization of the p53-rescue drug CP-31398 in vitro and in living cellsOncogene, 2002
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999